GSK, the British pharmaceutical giant, has significantly raised its long-term sales outlook for the period between 2026 and 2031. The company anticipates that the launch of new drugs and vaccines will propel its annual sales to reach £38 billion by the beginning of the next decade. One of the key factors contributing to this positive projection is the hugely successful release … [Read more...] about GSK Raises Long-Term Sales Outlook
vaccines
Merck Reports Strong Q4 Earnings and Sales
Merck & Co. Inc. has announced its fourth-quarter earnings and sales results, exceeding expectations. The company's success in the cancer and vaccine segments has contributed to its exceptional performance. Financial Highlights Net loss of $1.226 billion, or 48 cents per share, compared to a profit of $3.017 billion, or $1.18 per share, in the same quarter last … [Read more...] about Merck Reports Strong Q4 Earnings and Sales
